Discover 136 paid clinical trials in Missoula, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 136
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Missoula MT, Boise ID, Meridian ID, Renton WA,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & Responsive
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: Missoula MT, Colorado Springs CO, Bakersfield CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase3, Recruiting
Active & Responsive
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
for
Postmenopausal Osteoporosis
Location: Missoula MT, Burien WA, Albuquerque NM, Tucson AZ,
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
for
Recurrent Endometrial Carcinoma,
Location: Missoula MT, Anaconda MT, Kalispell MT, Great Falls MT,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05554328
Phase2, Recruiting
Active & Responsive
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Missoula MT, Kalispell MT, Great Falls MT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Active & Responsive
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
for
Plantar Fibromatosis, Ledderhose Disease
Location: Missoula MT, Billings MT, Bountiful UT,
Sponsor: Endo Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06151197
Phase3, Recruiting
Active & Responsive
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
for
Obesity, Overweight
Location: Missoula MT, Meridian ID, Corvallis OR, Carson City NV,